GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OncoZenge AB (FRA:8LY) » Definitions » Other Financing

OncoZenge AB (FRA:8LY) Other Financing : €0.00 Mil (TTM As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is OncoZenge AB Other Financing?

OncoZenge AB's Other Financing for the three months ended in Sep. 2024 was €0.00 Mil.

OncoZenge AB's Other Financing for the trailing twelve months (TTM) ended in Sep. 2024 was €0.00 Mil.

OncoZenge AB Other Financing Historical Data

The historical data trend for OncoZenge AB's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OncoZenge AB Other Financing Chart

OncoZenge AB Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Other Financing
- - - -

OncoZenge AB Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

OncoZenge AB Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OncoZenge AB Other Financing Related Terms

Thank you for viewing the detailed overview of OncoZenge AB's Other Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

OncoZenge AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OncoZenge AB (FRA:8LY) » Definitions » Other Financing
Comparable Companies
OSTO:MODTX OSTO:FLUI OSTO:CMOTEC B XSAT:DBP B OSTO:PILA OSTO:SPAGO XSAT:APTA XSAT:PHAL XSAT:CHOSA OSTO:CYXO OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
ONCOZ:Sweden
Address
Gustavslundsvagen 34, Bromma, SWE, 167 51
Website
https://www.oncozenge.com
OncoZenge AB is a pharmaceutical company that is developing a new treatment for effective pain relief in patients suffering from oral pain caused by radiation therapy and chemotherapy for cancer. In phase 2 patient studies, the company's product candidate BupiZenge displayed pain relief compared with standard therapy. It focuses on implementing a phase development program as a basis for regulatory approvals and product launches.

OncoZenge AB Headlines

No Headlines